Détails
Marque
Collection
n.c
Parution
2023-04-11
Pages
142 pages
EAN papier
9783031287312
Langue
Anglais
Informations ebook
EAN PDF
9783031287329
Prix
45,93 €
En savoir plus
Nb pages copiables 1
Nb pages imprimables 14
Taille du fichier 6339 Ko
EAN EPUB
9783031287329
Prix
45,93 €
En savoir plus
Nb pages copiables 1
Nb pages imprimables 14
Taille du fichier 9206 Ko
Compatibilité

mobile-and-tablet Pour vérifier la compatibilité avec vos appareils,
consultez la page d'aide

Auteur(s) du livre


Adrian Hobson, FRSC, is a Senior Research Fellow at Abbvie, and an adjunct Professor of Chemistry at Clark University in Worcester, MA, USA. With 30 years of experience as a medicinal chemist, he started his journey at Boots Pharmaceuticals, Nottingham UK, where he worked on anti-depressants and anti-psychotics, and in the Special Synthesis group making metabolites and possible impurities. After the company was acquired by BASF in 1994, he formed the High Speed Analoging team, working there for 6 years until he transferred to the BASF Bioresearch Corporation at Worcester, MA, USA, where he formed a new High Speed Analoging team to support both oncology and immunology. He spent the next 12 years working in medicinal chemistry on kinase, GPCR and NHR targets including selective glucocorticoid receptor modulators. When AbbVie split from Abbott, Dr Hobson switched his attention to immunology antibody-drug conjugates, where he has pioneered the use of glucocorticoid receptor modulators (GRM) as a payload for antibody-drug conjugates.


Avis clients

Suggestions personnalisées

Restez informé(e) des événements et promotions ebook

Paiements sécurisés

Paiements sécurisés